Dr Melissa Chen
Learn more about Monash Health’s Haematology team.
Dr Melissa Chen
BMedSc, MBBS, FRACP, FRCPA
Dr Melissa Chen is a clinical and laboratory haematologist at Monash Health and Eastern Health. She has an interest in malignant haematology, in particular myeloproliferative neoplasms, myelodysplasia, lymphoma and myeloma.
After completion of Haematology training, she undertook a 2 year research fellowship at Monash Health and is currently a principle investigator in clinical trials involving new treatment approaches for patients with myelofibrosis, and TTR amyloidosis.
Recent publications (last 5 years)
- Clinical outcomes of chronic myeloid leukaemia patients taking asciminib through a Managed Access Programme (MAP) in Australia. Chee L, Lee N, Grigg A, Chen M, Schwarer A, Szer J, Ratnasingam S, Raj S, Lukito P, Yeung D, Hughes T, Shanmuganathan N. Intern Med J. 2024 Jul;54(7):1214-1218.
- Plasma Cell Directed Therapy for Immune Thrombotic Thrombocytopenic Purpura (iTTP). Chen M, Shortt J. Transfus Med Rev. 2022 Oct;36(4):204-214.
- Clinical illness with viable severe acute respiratory coronavirus virus 2 (SARS-CoV-2) virus presenting 72 days after infection in an immunocompromised patient. Hughes CM, Gregory GP, Pierce AB, Druce JD, Catton M, Chong B, Sherry NL, Graham M, Chen M, Salvaris R, Eise N, Lee JYH, McQuilten Z, Crouch S, Looker C, Korman TM, Stuart RL. Infect Control Hosp Epidemiol. 2022 Jun;43(6):820-822.